期刊文献+

盐酸椒苯酮胺致突变实验 被引量:4

Investigation on potential mutagenicity of piperphentonamine hydrochloride
下载PDF
导出
摘要 目的探讨盐酸椒苯酮胺的致突变性。方法用Ames试验、昆明种小鼠骨髓微核试验及中国仓鼠肺细胞染色体畸变试验研究盐酸椒苯酮胺的致突变性。结果盐酸椒苯酮胺Ames试验,小鼠微核试验及中国仓鼠肺细胞染色体畸变三项试验结果均为阴性。结论盐酸椒苯酮胺无致突变作用。 Objective To study the potential mutagenicity of piperphentonamine hydrochloride.Methods Ames,Micronucleus assay and chromosomal aberration tests were studied.Results The results of Ames,Micronucleus assay and chromosomal aberration tests were all negative.Conclusions Piperphentonamine hydrochloride has no mutagenicity in this experimental system.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第19期4747-4749,共3页 Chinese Journal of Gerontology
基金 国家"十二五"新药创制科技重大专项(No.2011ZX091011003) 科技部创新基金项目(No.10C26214412687) 广东省中国科学院全面战略合作项目(No.2009B091300065) 广州市专利技术产业化示范项目(No.200903) 广州市重大专项课题(No.2008A1-E4161)
关键词 盐酸椒苯酮胺 致突变性 AMES试验 微核试验 染色体畸变 Piperphentonamine hydrochloride Mutagenicity Ames Micronucleus assay Chromosomal aberration test
  • 相关文献

参考文献7

  • 1杨向阳,李若冰,万华印.新型钙增敏剂左西孟旦和盐酸椒苯酮胺研究进展[J].国际药学研究杂志,2010,37(1):32-35. 被引量:26
  • 2万华印.心血管化学创新药盐酸椒苯酮胺(PPTA)[EB/OL].(2004-06-30)[2009-08-01].http://www.gzkjcg.gov.cn/Default.aspx?tabid=183&ItemId=877&retumTabld.
  • 3李茹冰,万华印,邓凤君,等.心血管创新药盐酸椒苯酮胺[C]∥中国药理学会药学监护专业委员会第一届第四次学术研讨会论文摘要汇编.北京:中国药理学会,2008:44.
  • 4牟英,孟志云,窦桂芳.椒苯酮胺在比格犬体内的药代动力学研究[J].中国血液流变学杂志,2006,16(3):338-340. 被引量:12
  • 5万华印,李茹冰,李永贺,等.椒苯酮胺、椒苯酮胺盐及其制备方法:中国,02125318.8[P].2004-09-01.
  • 6万华印,李茹冰,李永贺,等.椒苯酮胺或其盐用作制备治疗心血管疾病药物的应用:中国,02125316.1[P].2005-06-15.
  • 7万华印,李茹冰,李永贺,等.N-甲基胡椒乙胺盐的制备方法:中国,02125317.X[P].2004-09-15.

二级参考文献34

  • 1牟英,孟志云,窦桂芳.椒苯酮胺在比格犬体内的药代动力学研究[J].中国血液流变学杂志,2006,16(3):338-340. 被引量:12
  • 2Parissis JT, Andreadou I, Bistola V, et al. Novel biologic mechanisms of levosimendan and its effect on the failing heart[J]. Expert Opin Invest Drags, 2008, 17(8) :1143 -1150.
  • 3Antoniades C, Tousoulis D, Koumallos N, et al. Levosimendan: beyond its simple inotropic effect in heart failure[J]. Pharmacol Ther. 2007, 114(2) :184 - 197.
  • 4Pinto BB, Rehberg S, Ertmer C, et al. Role of levosimendan in sepsis and septic shock [ J ]. Curr Opin Anaesthesiol, 2008, 21 (2) :168 - 177.
  • 5Lehtonen L, Poder P. The utility of levosimendan in the treatment of heart failure[J]. Ann Med, 2007, 39( 1 ) :2 - 17.
  • 6Archan S, Toiler W, Levosimendan: current status and future prospects[ J ]. Curr Opin Anaesthesiol, 2008, 21 ( 1 ) :78 - 84.
  • 7Kota B, Prasad AS, Economides C, et al. Levosimendan and calcium sensitization of the contractile proteins in cardiac muscle : impact on heart failure[J]. J Cardiovasc Pharmacol Ther, 2008, 13(4) :269 -278.
  • 8Silva-Cardoso J, Ferreira J, Oliveira-Soares A, et al. Effectiveness and safety of levosimendan in clinical practice[J]. Rev Port Cardiol, 2009, 28 (2) : 143 - 154.
  • 9Duygu H, Nalbantgil S, Zoghi M, et al. Comparison of ischemic side effects of levosimendan and dobutamine with integrated backscatter analysis[J]. Clin Cardiol, 2009, 32(4) : 187 - 192.
  • 10Yilmaz MB, Yontar C, Erdem A, et al. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure [ J ]. Heart Vessels, 2009, 24(1) :16 -21.

共引文献27

同被引文献54

  • 1范礼理,滕健,张润东,赵德育.羟苯氨酮保护大鼠心脏对抗心肌缺血-再灌注损伤[J].药学学报,2005,40(6):507-512. 被引量:13
  • 2孙世明,何林,吴正中,荣祖元,朱洁.注射用阿克拉霉素A固体脂质纳米粒小鼠体内抗肝癌活性及急性毒性研究[J].中国药房,2005,16(18):1372-1374. 被引量:6
  • 3牟英,孟志云,窦桂芳.椒苯酮胺在比格犬体内的药代动力学研究[J].中国血液流变学杂志,2006,16(3):338-340. 被引量:12
  • 4李茹冰,万华印,邓凤君,等.心血管创新药盐酸椒苯酮胺[C]∥中国药理学会药学监护专业委员会第一届第四次学术研讨会论文摘要汇编.北京:中国药理学会,2008:44.
  • 5徐叔云.药理实验方法学[M].北京:人民卫生出版社,1992.445.
  • 6周力践,衷小惠,刘铁球.椒苯酮胺或其盐用作制备治疗心血管疾病药物的应用:中国,02125316.1[P].2003.02.12.
  • 7国家食品药品监督管理总局.国家食品药品监督管理总局临床批件/http://appl.sfda.gov.cn/datasearch/face3/base.jsp?tableld=16&tableName=TABLEl6&title=%D2%A9%C6%B7%D7%A2%B2%El%C5%FA%BC%FE%B7%A2%CB%CD%DO%C5%CF%A2&bcId=124356691500929088825573428019[Z].2013.
  • 8Yang F, Zhang Q, Liang Q, et al. Bioavailability enhancement of paclitaxel via a novel oral drug delivery system : Paclitaxel-loaded glycyrrhizic acid micelles [ J ]. Molecules ,2015,20 ( 3 ) :4337-4356.
  • 9Shi A,Hu X,Li R,et al.Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,doi:10.1016/j.jchromb.2012.09.031.
  • 10Shi A,Hu X,Li R,et al.Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers[J].J Chromatogr B Analyt Technol Biomed Life Sci,2012,doi:10.1016/j.jchromb.2012.09.031.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部